BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 11219497)

  • 21. Superiority of interleukin-12-transduced murine lung cancer cells to GM-CSF or B7-1 (CD80) transfectants for therapeutic antitumor immunity in syngeneic immunocompetent mice.
    Sumimoto H; Tani K; Nakazaki Y; Tanabe T; Hibino H; Wu MS; Izawa K; Hamada H; Asano S
    Cancer Gene Ther; 1998; 5(1):29-37. PubMed ID: 9476964
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adenovirus-mediated lymphotactin gene transfer improves therapeutic efficacy of cytosine deaminase suicide gene therapy in established murine colon carcinoma.
    Ju DW; Tao Q; Cheng DS; Zhang W; Zhang M; Hamada H; Cao X
    Gene Ther; 2000 Feb; 7(4):329-38. PubMed ID: 10694814
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IL-10 expression by CT26 colon carcinoma cells inhibits their malignant phenotype and induces a T cell-mediated tumor rejection in the context of a systemic Th2 response.
    Adris S; Klein S; Jasnis M; Chuluyan E; Ledda M; Bravo A; Carbone C; Chernajovsky Y; Podhajcer O
    Gene Ther; 1999 Oct; 6(10):1705-12. PubMed ID: 10516719
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Construction of expression vector of hTERT- hIL18 fusion gene and induction of cytotoxic T lymphocyte response against hTERT.
    Tong XM; Zheng SE; Bader A; Yao HP; Wu NP; Altmeyer P; Brockmeyer NH; Jin J
    Eur J Med Res; 2008 Jan; 13(1):7-14. PubMed ID: 18226991
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention of angiogenesis by naked DNA IL-12 gene transfer: angioprevention by immunogene therapy.
    Morini M; Albini A; Lorusso G; Moelling K; Lu B; Cilli M; Ferrini S; Noonan DM
    Gene Ther; 2004 Feb; 11(3):284-91. PubMed ID: 14737088
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cotransduction of CCL27 gene can improve the efficacy and safety of IL-12 gene therapy for cancer.
    Gao JQ; Kanagawa N; Motomura Y; Yanagawa T; Sugita T; Hatanaka Y; Tani Y; Mizuguchi H; Tsutsumi Y; Mayumi T; Okada N; Nakagawa S
    Gene Ther; 2007 Mar; 14(6):491-502. PubMed ID: 17203106
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interleukin-12 gene therapy of a weakly immunogenic mouse mammary carcinoma results in reduction of spontaneous lung metastases via a T-cell-independent mechanism.
    Rakhmilevich AL; Janssen K; Hao Z; Sondel PM; Yang NS
    Cancer Gene Ther; 2000 Jun; 7(6):826-38. PubMed ID: 10880012
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of the interleukin-21 gene in murine colon carcinoma cells generates systemic immunity in the inoculated hosts.
    Ugai S; Shimozato O; Kawamura K; Wang YQ; Yamaguchi T; Saisho H; Sakiyama S; Tagawa M
    Cancer Gene Ther; 2003 Mar; 10(3):187-92. PubMed ID: 12637939
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antitumor effects of interleukin-18 gene-modified hepatocyte cell line on implanted liver carcinoma.
    Leng J; Zhang L; Yao H; Cao X
    Chin Med J (Engl); 2003 Oct; 116(10):1475-9. PubMed ID: 14570604
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Injection of complementary DNA encoding interleukin-12 inhibits tumor establishment at a distant site in a murine renal carcinoma model.
    Tan J; Newton CA; Djeu JY; Gutsch DE; Chang AE; Yang NS; Klein TW; Hua Y
    Cancer Res; 1996 Aug; 56(15):3399-403. PubMed ID: 8758901
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retroviral vector-mediated lymphokine gene transfer into human renal cancer cells.
    Gastl G; Finstad CL; Guarini A; Bosl G; Gilboa E; Bander NH; Gansbacher B
    Cancer Res; 1992 Nov; 52(22):6229-36. PubMed ID: 1423266
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor cells cotransfected with interleukin-7 and B7.1 genes induce CD25 and CD28 on tumor-infiltrating T lymphocytes and are strong vaccines.
    Cayeux S; Beck C; Aicher A; Dörken B; Blankenstein T
    Eur J Immunol; 1995 Aug; 25(8):2325-31. PubMed ID: 7545119
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination nonviral interleukin-2 gene immunotherapy for head and neck cancer: from bench top to bedside.
    O'Malley BW; Li D; McQuone SJ; Ralston R
    Laryngoscope; 2005 Mar; 115(3):391-404. PubMed ID: 15744147
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rejection of disseminated metastases of colon carcinoma by synergism of IL-12 gene therapy and 4-1BB costimulation.
    Chen SH; Pham-Nguyen KB; Martinet O; Huang Y; Yang W; Thung SN; Chen L; Mittler R; Woo SL
    Mol Ther; 2000 Jul; 2(1):39-46. PubMed ID: 10899826
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Construction of a RU486 inducible recombinant adenoviral vector carrying murine interleukin-12 gene and experimental treatment of colonic carcinoma].
    Chen J; Liu XS; Wang F; Xue XC; Fang GE; Su CQ; Qian QJ
    Zhonghua Yi Xue Za Zhi; 2009 May; 89(20):1372-6. PubMed ID: 19671324
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vaccination with an adenoviral vector encoding the tumor antigen directly linked to invariant chain induces potent CD4(+) T-cell-independent CD8(+) T-cell-mediated tumor control.
    Sorensen MR; Holst PJ; Pircher H; Christensen JP; Thomsen AR
    Eur J Immunol; 2009 Oct; 39(10):2725-36. PubMed ID: 19637230
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inoculation of human interleukin-17 gene-transfected Meth-A fibrosarcoma cells induces T cell-dependent tumor-specific immunity in mice.
    Hirahara N; Nio Y; Sasaki S; Minari Y; Takamura M; Iguchi C; Dong M; Yamasawa K; Tamura K
    Oncology; 2001; 61(1):79-89. PubMed ID: 11474253
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Postoperative immuno-gene therapy of murine bladder tumor by in vivo administration of retroviruses expressing mouse interferon-gamma.
    Shiau AL; Lin CY; Tzai TS; Wu CL
    Cancer Gene Ther; 2001 Jan; 8(1):73-81. PubMed ID: 11219496
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A convenient cancer vaccine therapy with in vivo transfer of interleukin 12 expression plasmid using gene gun technology after priming with irradiated carcinoma cells.
    Nishitani MA; Sakai T; Ishii K; Zhang M; Nakano Y; Nitta Y; Miyazaki J; Kanayama HO; Kagawa S; Himeno K
    Cancer Gene Ther; 2002 Feb; 9(2):156-63. PubMed ID: 11857033
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Natural killer cells play a role in MHC class I in vivo induction in tumor cells that are MHC negative in vitro.
    Kijima M; Saio M; Oyang GF; Suwa T; Miyauchi R; Kojima Y; Imai H; Nakagawa J; Nonaka K; Umemura N; Nishimura T; Takami T
    Int J Oncol; 2005 Mar; 26(3):679-84. PubMed ID: 15703823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.